Cargando…
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that govern the pathophysiology of different disease courses remain poorly defined. Across the spectrum of disease severity, COVID-19 impairs both innate and adaptive host immune responses by activating innate immune...
Autores principales: | Rowlands, Marianna, Segal, Florencia, Hartl, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250151/ https://www.ncbi.nlm.nih.gov/pubmed/34220859 http://dx.doi.org/10.3389/fimmu.2021.697405 |
Ejemplares similares
-
Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019) -
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good
por: Grassi, Germana, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019) -
Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)